Cramer's 'Mad Money' Recap: Daktronics on Track

Very few people actually know about this hidden part of Safeway, he said, "but as soon as the Street figures things out, the stock should go up."

He also mentioned Safeway's supermarket business is "great" and is "financially sound enough to add a half-billion dollars to its buyback program last Friday and offer a dividend."

Cramer advised viewers to get into the stock before its analyst meeting, scheduled to take place Tuesday. However, he warned people not to buy the stock after hours and suggested buying it Tuesday morning instead.

Blackhawk's business is "too good to ignore," and Safeway's supermarket business is getting better, so people should get in before Safeway's stock is upgraded, Cramer said.

Allergan Grinning

Cramer welcomed Allergan (AGN Quote) CEO David Pyott onto the show and asked him to talk about his company's medical pipeline.

Pyott said his company has an early-stage program for neuropathic pain, and also that 50% of the company is ophthalmology, a sector in which Allergan has been the fastest-growing company for the last four years.

"The great position we have is that Allergan is the largest company in the world in the medical aesthetics space," Pyott said. "If we look at the plastic surgeon customer channel, the three largest consumables are breast implants, Botox and dermal fillers, where we have Juviderm."